0001193125-26-059545
SEC filingRein Therapeutics Inc. filed an 8-K on February 19, 2026, with Items listed as N/A. An external hint references Item 5.02 regarding a potential departure, election, or appointment of directors or certain officers effective February 1, but no specific details are disclosed in the document content.